FORTITUDE Bioresorbable Drug-Eluting Coronary Stent

· Amaranth Medical Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FORTITUDE Bioresorbable Drug-Eluting Coronary Stent, covering 2016-06-08 to 2016-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent [Phase 2]

See pricing